Skip to content
Disclosery

EXANE DERIVATIVES: AUPH position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on AUPH, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 8,683 AUPH shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 8,683 shares
    Change vs previous 13F 0 shares

    0.05% of the 13F portfolio, value $87,246.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 8,683 shares
    Change vs previous 13F +1,182 shares

    0.03% of the 13F portfolio, value $107,489.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 7,501 shares
    Change vs previous 13F -6,828 shares

    0.04% of the 13F portfolio, value $171,540.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 14,329 shares
    Change vs previous 13F +1,185 shares

    0.08% of the 13F portfolio, value $317,089.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 13,144 shares
    Change vs previous 13F +4,404 shares

    0.04% of the 13F portfolio, value $156,541.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 8,740 shares
    Change vs previous 13F -1,388 shares

    0.03% of the 13F portfolio, value $113,484.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 10,128 shares
    Change vs previous 13F +5,028 shares

    0.04% of the 13F portfolio, value $140,064.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 5,100 shares
    Change vs previous 13F not available

    0.02% of the 13F portfolio, value $75,119.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).